Syk tyrosine kinase is overexpressed in the majority of peripheral T- and NK-cell lymphomas, and represents a potential therapeutic target.

被引：0
|
作者：
Feldman, Andrew L. [1 ]
Sun, David X. [1 ]
Law, Mark E. [1 ]
Novak, Anne J. [2 ]
Attygalle, Ayoma D. [3 ]
Thorland, Erik C. [1 ]
Fink, Stephanie R. [1 ]
Vrana, Julie A. [1 ]
Caron, B. Lynn [1 ]
Morice, William G. [1 ]
Remstein, Ellen D. [1 ]
Grogg, Karen L. [1 ]
Kurtin, Paul J. [1 ]
Macon, William R. [1 ]
Dogan, Ahmet [1 ]
机构：
[1] Mayo Clin, Lab Med & Pathol, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Royal Marsden Hosp, London SW3 6JJ, England
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.690.690
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
690
引用
收藏
页码：212A / 212A
页数：1
相关论文
共 50 条
  • [21] PD-L1 Expression in T and NK-cell Lymphomas: A New Therapeutic Target
    Anderson, Joshua
    Wang, Linlin
    LABORATORY INVESTIGATION, 2017, 97 : 336A - 336A
  • [22] PD-L1 Expression in T and NK-cell Lymphomas: A New Therapeutic Target
    Anderson, Joshua
    Wang, Linlin
    MODERN PATHOLOGY, 2017, 30 : 336A - 336A
  • [23] Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas
    Bhansali, Rahul S.
    Barta, Stefan K.
    CANCERS, 2023, 15 (03)
  • [24] Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies
    El-Mallawany, N. K.
    Frazer, J. K.
    Van Vlierberghe, P.
    Ferrando, A. A.
    Perkins, S.
    Lim, M.
    Chu, Y.
    Cairo, M. S.
    BLOOD CANCER JOURNAL, 2012, 2 : e65 - e65
  • [25] Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies
    N K El-Mallawany
    J K Frazer
    P Van Vlierberghe
    A A Ferrando
    S Perkins
    M Lim
    Y Chu
    M S Cairo
    Blood Cancer Journal, 2012, 2 : e65 - e65
  • [26] Primary and secondary central nervous system mature T- and NK-cell lymphomas
    Pang, Yifan
    Chihara, Dai
    SEMINARS IN HEMATOLOGY, 2021, 58 (02) : 123 - 129
  • [27] Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
    Ng, Samuel Y.
    Yoshida, Noriaki
    Christie, Amanda L.
    Ghandi, Mahmoud
    Dharia, Neekesh V.
    Dempster, Joshua
    Murakami, Mark
    Shigemori, Kay
    Morrow, Sara N.
    Van Scoyk, Alexandria
    Cordero, Nicolas A.
    Stevenson, Kristen E.
    Puligandla, Maneka
    Haas, Brian
    Lo, Christopher
    Meyers, Robin
    Gao, Galen
    Cherniack, Andrew
    Louissaint, Abner, Jr.
    Nardi, Valentina
    Thorner, Aaron R.
    Long, Henry
    Qiu, Xintao
    Morgan, Elizabeth A.
    Dorfman, David M.
    Fiore, Danilo
    Jang, Julie
    Epstein, Alan L.
    Dogan, Ahmet
    Zhang, Yanming
    Horwitz, Steven M.
    Jacobsen, Eric D.
    Santiago, Solimar
    Ren, Jian-Guo
    Guerlavais, Vincent
    Annis, D. Allen
    Aivado, Manuel
    Saleh, Mansoor N.
    Mehta, Amitkumar
    Tsherniak, Aviad
    Root, David
    Vazquez, Francisca
    Hahn, William C.
    Inghirami, Giorgio
    Aster, Jon C.
    Weinstock, David M.
    Koch, Raphael
    NATURE COMMUNICATIONS, 2018, 9
  • [28] Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
    Samuel Y. Ng
    Noriaki Yoshida
    Amanda L. Christie
    Mahmoud Ghandi
    Neekesh V. Dharia
    Joshua Dempster
    Mark Murakami
    Kay Shigemori
    Sara N. Morrow
    Alexandria Van Scoyk
    Nicolas A. Cordero
    Kristen E. Stevenson
    Maneka Puligandla
    Brian Haas
    Christopher Lo
    Robin Meyers
    Galen Gao
    Andrew Cherniack
    Abner Louissaint
    Valentina Nardi
    Aaron R. Thorner
    Henry Long
    Xintao Qiu
    Elizabeth A. Morgan
    David M. Dorfman
    Danilo Fiore
    Julie Jang
    Alan L. Epstein
    Ahmet Dogan
    Yanming Zhang
    Steven M. Horwitz
    Eric D. Jacobsen
    Solimar Santiago
    Jian-Guo Ren
    Vincent Guerlavais
    D. Allen Annis
    Manuel Aivado
    Mansoor N. Saleh
    Amitkumar Mehta
    Aviad Tsherniak
    David Root
    Francisca Vazquez
    William C. Hahn
    Giorgio Inghirami
    Jon C. Aster
    David M. Weinstock
    Raphael Koch
    Nature Communications, 9
  • [29] An Orally Available Syk Tyrosine Kinase Inhibitor Induces Apoptosis in Peripheral T-Cell Lymphomas Overexpressing Activated Syk
    Wilcox, R.
    Sun, D.
    Remstein, E. D.
    Dogan, A.
    Ansell, S.
    Feldman, A. L.
    MODERN PATHOLOGY, 2009, 22 : 291A - 291A
  • [30] An Orally Available Syk Tyrosine Kinase Inhibitor Induces Apoptosis in Peripheral T-Cell Lymphomas Overexpressing Activated Syk
    Wilcox, R.
    Sun, D.
    Remstein, E. D.
    Dogan, A.
    Ansell, S.
    Feldman, A. L.
    LABORATORY INVESTIGATION, 2009, 89 : 291A - 291A
12345